The Delhi High Court has upheld an order permitting Dr Reddy's Laboratories to manufacture semaglutide in India solely for export, rejecting Novo Nordisk's appeal in the ongoing patent dispute ...
A Division Bench of the Delhi High Court on Monday upheld an order permitting Indian pharma giant Dr Reddy's to manufacture diabetes management and weight-loss ...
Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under ...
Dr Reddy's Laboratories is set to launch its generic semaglutide injection, Obeda, in India this March, as patent protection ...
A division Bench of justices C. Hari Shankar and Om Prakash Shukla said that it did not find reason to interfere with a ...
Dr Reddy’s Laboratories said the USFDA has classified the inspection of its Srikakulam formulations manufacturing facility as Voluntary Action Indicated (VAI) and issued the Establishment Inspection ...
Stay informed with the Dr Reddys Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...
Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...
It’s critical to keep your workplace equipment clean and calibrated—especially in the realm of pharmaceutical manufacturing. Now, Dr. Reddy’s failure to uphold those standards has landed the Indian ...
Dr. Reddy’s Laboratories announced Feb. 27 it entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group Ltd. Terms of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results